for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Astellas Pharma Says Final Prosper Results Show Xtandi Significantly Extends Overall Survival In Men With Non-Metastatic Castration-Resistant Prostate Cancer

May 29 (Reuters) - Astellas Pharma Inc:

* FINAL PROSPER RESULTS SHOW XTANDI SIGNIFICANTLY EXTENDS OVERALL SURVIVAL IN MEN WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up